Elliott Lang on Nostr: Pfizer, Moderna Stock Prices Down Considerably in 2023 Pfizer's shares are down about ...
Pfizer, Moderna Stock Prices Down Considerably in 2023
Pfizer's shares are down about 40 percent, and Moderna's shares are down 55 percent for this year. Novavax, which makes a COVID-19 vaccine that doesn't use mRNA technology, has seen its stock drop by 63 percent for the year.
Pfizer recently cut around $9 billion from its sales forecast due to declining demand for its COVID-19 vaccine and anti-viral drug Paxlovid.
https://www.theepochtimes.com/article/pfizer-moderna-stock-prices-down-considerably-in-2023-post-5514116?utm_source=VI&src_src=VI&utm_campaign=VI_BN5optin&src_cmp=VI_BN5optin&utm_medium=EmailMk&utm_term=BN5-10-26-2023&autoemail=elliottlang%40gmail.com&utm_content=brnews1
Pfizer's shares are down about 40 percent, and Moderna's shares are down 55 percent for this year. Novavax, which makes a COVID-19 vaccine that doesn't use mRNA technology, has seen its stock drop by 63 percent for the year.
Pfizer recently cut around $9 billion from its sales forecast due to declining demand for its COVID-19 vaccine and anti-viral drug Paxlovid.
https://www.theepochtimes.com/article/pfizer-moderna-stock-prices-down-considerably-in-2023-post-5514116?utm_source=VI&src_src=VI&utm_campaign=VI_BN5optin&src_cmp=VI_BN5optin&utm_medium=EmailMk&utm_term=BN5-10-26-2023&autoemail=elliottlang%40gmail.com&utm_content=brnews1